NHS National Framework for Transition products commencing 1 May 2024

Concepts

• pharmaceutical products
• runcorn
• nhs england
• nhs national framework
• chain - nhs medicines value
• transition products
• nhs national framework for transition
• nhs england none
• cm/tns/05/2024 period of framework agreement
• the framework agreement

Location

Description

Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months) CM/TNS/05/2024/02 - Apixaban, Sapropterin Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-05-2024 Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-05-2024.docx Document No. 05a(i) - Selectt Offer Schedule - CM_TNS_05_2024_01 Document No. 05a(i) - Selectt Offer Schedule - CM_TNS_05_2024_01.xml Document No. 07a - Quality control technical sheet CM-TNS-05-2024 Document No. 07a - Quality control technical sheet CM-TNS-05-2024.doc Document No. 01 - Invitation to offer covering letter CM-TNS-05-2024 Document No. 01 - Invitation to offer covering letter CM-TNS-05-2024.docx Document No. 05b(ii) - Tender Product Listing and Usage 02 Document No. 05b(ii) - Tender Product Listing and Usage 02.xlsx Document No. 09 - Participating Authorities CM-TNS-05-2024 Document No. 09 - Participating Authorities CM-TNS-05-2024.xls Document No. 02 - Terms of offer CM-TNS-05-2024 Document No. 02 - Terms of offer CM-TNS-05-2024.doc Document No. 05 - Selectt offer schedule instructions CM-TNS-05-2024 Document No. 05 - Selectt offer schedule instructions CM-TNS-05-2024.docx Document No. 06 - Form of offer CM-TNS-05-2024 Document No. 06 - Form of offer CM-TNS-05-2024.doc Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS CM-TNS-05-2024 Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS CM-TNS-05-2024.doc Document No. 08 - Confidential information schedule CM-TNS-05-2024 Document No. 08 - Confidential information schedule CM-TNS-05-2024.xls Document No. 05b(i) - Tender Product Listing and Usage 01 Document No. 05b(i) - Tender Product Listing and Usage 01.xlsx Document No. 05a(ii) - Selectt Offer Schedule - CM_TNS_05_2024_02 Document No. 05a(ii) - Selectt Offer Schedule - CM_TNS_05_2024_02.xml Document No. 04a - Quality Assurance Process CM-TNS-05-2024 Document No. 04a - Quality Assurance Process CM-TNS-05-2024.doc Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM-TNS-05-2024 Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM-TNS-05-2024.docx Document No. 05c - Contract technical specification CM-TNS-05-2024 Document No. 05c - Contract technical specification CM-TNS-05-2024.doc